Production (Stage)
Optimind Pharma Corp.
OMND
CNSX
02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 58.10K | 73.20K | 67.00K | 107.10K | 21.10K |
Total Receivables | 46.00K | 43.10K | 58.40K | 37.70K | 117.50K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 104.00K | 116.30K | 125.40K | 144.80K | 138.70K |
|
|||||
Total Current Assets | 104.00K | 116.30K | 125.40K | 144.80K | 138.70K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 138.70K | 152.00K | 162.40K | 181.40K | 175.50K |
|
|||||
Total Accounts Payable | 103.50K | 96.60K | 98.30K | 255.40K | 178.00K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 87.10K | 89.70K | 93.10K | 92.10K | 92.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 190.50K | 186.30K | 191.40K | 347.40K | 270.60K |
|
|||||
Total Current Liabilities | 190.50K | 186.30K | 191.40K | 347.40K | 270.60K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 87.10K | 89.70K | 93.10K | 92.10K | 92.60K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 190.50K | 186.30K | 191.40K | 347.40K | 270.60K |
|
|||||
Common Stock & APIC | 3.33M | 3.43M | 3.56M | 3.32M | 3.34M |
Retained Earnings | -3.49M | -3.58M | -3.71M | -3.61M | -3.55M |
Treasury Stock & Other | 112.50K | 115.90K | 120.30K | 119.00K | 119.70K |
Total Common Equity | -51.90K | -34.40K | -29.00K | -166.00K | -95.10K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -51.90K | -34.40K | -29.00K | -166.00K | -95.10K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -51.90K | -34.40K | -29.00K | -166.00K | -95.10K |
|